Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single- vs Double-injection Costoclavicular Block
NCT03595514Unknown
- Sponsor
- McGill University Health Centre
- Start
- Jul 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of lidocaine and bupivacaine in Upper extremity injury, sponsored by McGill University Health Centre. Primary endpoint: Onset time of brachial plexus blockade at 30 months. Status: unknown.
02
Drugs
lidocainebupivacaine
03
Conditions
Upper extremity injury
Beyond the preview
Go deeper on NCT03595514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03595514.